| Product Code: ETC9562474 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Phelan McDermid Syndrome Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Phelan McDermid Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Phelan McDermid Syndrome Market - Industry Life Cycle |
3.4 Sweden Phelan McDermid Syndrome Market - Porter's Five Forces |
3.5 Sweden Phelan McDermid Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Sweden Phelan McDermid Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sweden Phelan McDermid Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Phelan McDermid Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Phelan-McDermid Syndrome (PMS) in Sweden |
4.2.2 Advancements in medical research and technology leading to better understanding and treatment options |
4.2.3 Growing government support and funding for rare disease research and treatment |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals with expertise in managing PMS |
4.3.2 High treatment costs and lack of insurance coverage for some therapies |
4.3.3 Challenges in accessing specialized care and support services for individuals with PMS |
5 Sweden Phelan McDermid Syndrome Market Trends |
6 Sweden Phelan McDermid Syndrome Market, By Types |
6.1 Sweden Phelan McDermid Syndrome Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Chromosomal microarray, 2021- 2031F |
6.1.4 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Karyotyping, 2021- 2031F |
6.1.5 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By DNA sequencing, 2021- 2031F |
6.2 Sweden Phelan McDermid Syndrome Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Applied behavior analysis, 2021- 2031F |
6.2.3 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Occupational therapy, 2021- 2031F |
6.2.4 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Physical therapy, 2021- 2031F |
6.2.5 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Phelan McDermid Syndrome Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.3.4 Sweden Phelan McDermid Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Phelan McDermid Syndrome Market Import-Export Trade Statistics |
7.1 Sweden Phelan McDermid Syndrome Market Export to Major Countries |
7.2 Sweden Phelan McDermid Syndrome Market Imports from Major Countries |
8 Sweden Phelan McDermid Syndrome Market Key Performance Indicators |
8.1 Average age of diagnosis for individuals with PMS in Sweden |
8.2 Number of clinical trials and research studies focused on PMS in the country |
8.3 Percentage of healthcare facilities offering specialized care for individuals with rare genetic disorders |
9 Sweden Phelan McDermid Syndrome Market - Opportunity Assessment |
9.1 Sweden Phelan McDermid Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Sweden Phelan McDermid Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sweden Phelan McDermid Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Phelan McDermid Syndrome Market - Competitive Landscape |
10.1 Sweden Phelan McDermid Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Sweden Phelan McDermid Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here